Angela Beros

Angela Beros

Auto-generated profile, based on publicly available information

Angela Beros

School of Population Health, University of Auckland, Auckland, New Zealand

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2023 in BMJ Open Diabetes Research & Care
Verified
Journal Article
Open access
PDF file
ABAngela Beros
Angela Beros
JSJohn Sluyter
John Sluyter
RSRobert Scragg
Robert Scragg
Evidence is still emerging on the relationships of arterial stiffness with cardiac autonomic neuropathy (CAN) and peripheral neuropathy (PN). To our knowledge no systematic reviews or meta-analyses of these associations have been published. The purpose of our review was to assess the association of arterial stiffness with each type of neuropathy. Medline and Embase were systematically searched for observational studies of arterial stiffness and neuropathy. The systematic review of 60 studies (25 for CAN and 37 for PN), 59 including people with diabetes, showed arterial stiffness overall was higher in people with neuropathy than people without neuropathy. Forty-three studies were included in the meta-analysis. For CAN (19 studies), arterial stiffness was increased in people with neuropathy compared with without, as measured by pulse wave velocity (PWV) (mean difference: 1.32 m/s, 95% CI 0.82 to 1.81, p<0.00001), pulse pressure (PP) (mean difference: 6.25 mmHg, 95% CI 4.51 to 7.99, p<0.00001) or augmentation index (mean difference: 5.52%, 95% CI 3.46 to 7.58, p<0.0001). For PN (26 studies), arterial stiffness was increased in people with neuropathy compared with those without, as measured by PWV (mean difference: 1.22 m/s, 95% CI 0.87 to 1.58, p<0.00001) or PP (mean difference: 4.59 mmHg, 95% CI 2.96 to 6.22, p<0.00001). Only two cohort studies were located so the temporality of the association between arterial stiffness and neuropathy remains unclear. Increased arterial stiffness is associated with CAN and PN. PROSPERO registration number: CRD42019129563.

29 May 2024 in Journal Of Nephrology
Verified
Journal Article
Open access
PDF file
ABAngela Beros
Angela Beros
JSJohn Sluyter
John Sluyter
AHAlun D. Hughes
Alun D. Hughes
BHBernhard Hametner
Bernhard Hametner
SWSiegfried Wassertheurer
Siegfried Wassertheurer
RSRobert Scragg
Robert Scragg
Background/aims: Evidence from large population-based cohorts as to the association of arterial stiffness and incident chronic kidney disease (CKD) is mixed. This large population-based study aimed to investigate whether arterial stiffness, assessed oscillometrically, was associated with incident CKD. Methods: The study population comprised 4838 participants from the Vitamin D Assessment (ViDA) Study without known CKD (mean ± SD age = 66 ± 8). Arterial stiffness was assessed from 5 April, 2011 to 6 November, 2012 by way of aortic pulse wave velocity, estimated carotid-femoral pulse wave velocity, and aortic pulse pressure. Incident CKD was determined by linkage to national hospital discharge registers. Cox proportional hazards regression was used to assess the risk of CKD in relation to chosen arterial stiffness measures over the continuum and quartiles of values. Results: During a mean ± SD follow-up of 10.5 ± 0.4 years, 376 participants developed incident CKD. Following adjustment for potential confounders, aortic pulse wave velocity (hazard ratio (HR) per SD increase 1.69, 95% CI 1.45–1.97), estimated carotid-femoral pulse wave velocity (HR per SD increase 1.84, 95% CI 1.54–2.19), and aortic pulse pressure (HR per SD increase 1.37, 95% CI 1.22–1.53) were associated with the incidence of CKD. The risk of incident CKD was, compared to the first quartile, higher in the fourth quartile of aortic pulse wave velocity (HR 4.72, 95% CI 2.69–8.27; P trend < 0.001), estimated carotid-femoral pulse wave velocity (HR 4.28, 95% CI 2.45–7.50; P trend < 0.001) and aortic pulse pressure (HR 2.71, 95% CI 1.88–3.91; P trend < 0.001). Conclusions: Arterial stiffness, as measured by aortic pulse wave velocity, estimated carotid-femoral pulse wave velocity, and aortic pulse pressure may be utilised in clinical practice to help identify people at risk of future CKD. Trial registration: www.anzctr.org.au identifier:ACTRN12611000402943. Graphical

15 May 2024 in American Journal of Ophthalmology
Verified
Journal Article
Open access
ABAngela L. Beros
Angela L. Beros
JSJohn Sluyter
John Sluyter
AHAlun D. Hughes
Alun D. Hughes
BHBernhard Hametner
Bernhard Hametner
SWSiegfried Wassertheurer
Siegfried Wassertheurer
RSRobert Scragg
Robert Scragg
To investigate whether arterial stiffness, assessed oscillometrically, is associated with incident glaucoma in the Vitamin D Assessment (ViDA) Study cohort, aged 50-84 years. Prospective, population-based cohort study METHODS: : Arterial stiffness was assessed in 4713 participants without known glaucoma (mean±SD age = 66±8 years) from 5 April 2011 to 6 November 2012 by way of aortic PWV (aPWV), estimated carotid-femoral PWV (ePWV) and aortic PP (aPP). Incident glaucoma was identified through linkage to national prescription and hospital discharge registers. Relative risks of glaucoma for each arterial stiffness measure were estimated by Cox proportional hazards regression, over the continuum of values and by quartiles. During a mean±SD follow-up of 10.5±0.4 years, 301 participants developed glaucoma. Arterial stiffness, as measured by aPWV (Hazard ratio (HR) per SD increase, 1.36, 95%CI 1.14-1.62) and ePWV (HR per SD increase, 1.40, 95%CI 1.14-1.71) but not aPP (HR per SD increase, 1.06, 95%CI 0.92-1.23) was associated with incident glaucoma. When arterial stiffness was analyzed as a categorical variable, the highest quartiles of aPWV (HR, 2.62, 95%CI 1.52-4.52; Ptrend=0.007), ePWV (HR, 2.42, 95%CI 1.37-4.27; Ptrend=0.03), and aPP (HR, 1.68, 95%CI 1.10-2.5; Ptrend=0.02) were associated with the development of glaucoma. Arterial stiffness measured with a simple oscillometric device predicted the development of glaucoma and could potentially be used in clinical practice to help identify people at risk of this condition. It may also present a new therapeutic research avenue, including in respect of systemic antihypertensives.

23 January 2025 in BMJ Open Ophthalmology
Verified
Journal Article
Open access
PDF file
ABAngela L Beros
Angela L Beros
JSJohn D Sluyter
John D Sluyter
RSRobert Scragg
Robert Scragg
Background: This systematic review and meta-analysis assesses the association of arterial stiffness with age-related macular degeneration (AMD), glaucoma, retinal vein occlusion (RVO) and retinopathy (diabetic and hypertensive). Methods: Medline and Embase were systematically searched for observational studies of arterial stiffness and eye disease. Cohort studies were included if they estimated arterial stiffness using any measures based on the arterial waveform, with cross-sectional and case-control studies limited to measures of pulse wave velocity. We assessed the certainty of evidence using Grading of Recommendations, Assessment, Development and Evaluation. Results: The systematic review of 61 studies (six for AMD, ten for glaucoma, six for RVO and 39 for retinopathy) showed that arterial stiffness overall was higher in people with eye disease than people without eye disease. Forty-four cross-sectional and case-control studies were included in the meta-analysis. Arterial stiffness estimated by way of pulse wave velocity was associated with AMD (mean difference: 0.92 m/s, 95% CI 0.37 to 1.46; 2 studies; n=381; low certainty evidence), glaucoma (mean difference: 0.97 m/s, 95% CI 0.31 to 1.64; 7 studies; n=3418; low certainty evidence), RVO (mean difference: 2.79 m/s, 95% CI 2.02 to 3.55; 5 studies; n=414; very low certainty evidence) and retinopathy (1.48 m/s, 95% CI 0.1.16 to 1.81; 22 studies; n=10 074; low certainty evidence). The 19 cohort studies identified (five for AMD, three for glaucoma, one for RVO and 10 for retinopathy) indicated overall that increased arterial stiffness was associated with the future development of eye disease. Conclusions: Higher arterial stiffness is associated with AMD, glaucoma, RVO and retinopathy PROSPERO registration number: CRD42019129563.

22 December 2024 in Primary Care Diabetes
Verified
Journal Article
Open access
ABAngela L. Beros
Angela L. Beros
JSJohn Sluyter
John Sluyter
AHAlun D. Hughes
Alun D. Hughes
BHBernhard Hametner
Bernhard Hametner
SWSiegfried Wassertheurer
Siegfried Wassertheurer
RSRobert Scragg
Robert Scragg
This large population-based study aimed to investigate whether arterial stiffness, assessed oscillometrically, was associated with incident diabetes/prediabetes. The study sample comprised 4240 participants from the Vitamin D Assessment (ViDA) Study (mean±SD age = 66 ± 8). Arterial stiffness was assessed from 5 April 2011-6 November 2012 by way of aortic PWV (aPWV) and estimated carotid-femoral PWV (ecfPWV). Incident diabetes/prediabetes was determined by linkage to dispensed prescription and national hospital discharge registers. Cox proportional hazards regression was used to assess the risk of diabetes/prediabetes in relation to chosen arterial stiffness measures both overall and over quartiles. During a mean±SD follow-up of 10.5 ± 0.4 years, 470 participants developed diabetes/prediabetes. Following adjustment for potential confounders, aPWV (hazard ratio (HR) per SD increase, 1.40, 95 % CI, 1.19-1.64) was associated with the incidence of diabetes. The risk of incident diabetes was, compared to the first quartile, higher in the fourth quartile of aPWV (HR, 1.98, 95 %CI, 1.26-3.11)(Ptrend=0.01). Arterial stiffness, as measured by aPWV may be a useful predictor of incident diabetes that can be utilized in clinical practice.

20 October 2021 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
ABAngela Beros
Angela Beros
CFCindy Farquhar
Cindy Farquhar
HNHelen E Nagels
Helen E Nagels
MSMarian G Showell
Marian G Showell
AFAntonio Fernando
Antonio Fernando
VJVanessa Jordan
Vanessa Jordan